Community-reported Maintate side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Maintate Side Effect
Have You dealt with a Maintate side effect? Share your experience
Review Maintate Safety Reports submitted to FDA
Total Maintate reports: 2.Maintate FDA safety alerts: No.
Reported hospitalizations: 2.
Take Maintate Side Effects Survey, Discuss Maintate with others
FDA Reported Maintate Side Effects:
More About Maintate.
If you have questions about Maintate, you can ask a Health Expert or Ask Patient Community about Maintate.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Maintate Side Effects Report #5661617-X
Physician from JAPAN reported MAINTATE problem on Mar 03, 2008. Female patient, 68 years of age, weighting 141.1 lb, was diagnosed with hypertension, lipids abnormal, lacunar infarction and was treated with MAINTATE. After drug was administered, patient experienced the following problems/side effects: anti-platelet antibody positive, bleeding time prolonged, blood pressure increased, epistaxis, haemoptysis, haemorrhage subcutaneous, megakaryocytes decreased, platelet count decreased, thrombocytopenia. MAINTATE dosage: 2.5 MG/DAY. During the same period patient was treated with FLUVASTATIN, NORVASC, ASPIRIN, DIOVAN, DEPAS. Patient was hospitalized. Patient recovered.
Maintate Side Effects Report #5713844-0
MAINTATE problem was reported by a Consumer or non-health professional from JAPAN on Apr 07, 2008. Male patient, 39 years of age, was treated with MAINTATE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, continuous haemodiafiltration, oliguria, pleural effusion, pulmonary congestion, renal failure, shock, somnolence. MAINTATE dosage: 150 MG (150 MG, 1 IN 1 D). During the same period patient was treated with AMLODIPINE. Patient was hospitalized. Patient recovered.

